Jorge A Hernandez, MD | |
755 N 11th St, Suite P2200, Beaumont, TX 77702-1500 | |
(409) 892-1192 | |
(409) 924-9012 |
Full Name | Jorge A Hernandez |
---|---|
Gender | Male |
Speciality | Interventional Cardiology |
Experience | 33 Years |
Location | 755 N 11th St, Beaumont, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356338347 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | K5116 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Home Care Elite Llc | Nederland, TX | Home health agency |
Christus Southeast Texas- St Elizabeth | Beaumont, TX | Hospital |
Baptist Beaumont Hospital | Beaumont, TX | Hospital |
Christus Jasper Memorial Hospital | Jasper, TX | Hospital |
Tyler County Hospital | Woodville, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cardiac Cath Lab Of Beaumont, Lp | 2466630421 | 4 |
Advanced Cardiovascular Specialists Llp | 9032179791 | 12 |
News Archive
Asset Recovery Corporation, a leader in environmentally-sound IT asset disposal solutions, announced today that it has been certified by the National Association for Information Destruction (NAID) for computer hard drive sanitization and destruction. Both its plant-based and mobile solutions received certification.
Researchers, including a team from Children's National Health System, have identified head circumference and head tilting reflex as two reliable biomarkers in the identification of autism spectrum disorders (ASD) in children that are between 9 and 12 months of age.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.
"Despite the tremendous progress that has been achieved in the response to HIV/AIDS, it is urgent that efforts be redoubled to end this global epidemic, top United Nations officials stressed Monday, highlighting in particular the need to expand services and scale up resources," the U.N. News Centre reports.
› Verified 6 days ago
Entity Name | Christus Health Southeast Texas |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427370477 PECOS PAC ID: 3476460049 Enrollment ID: O20040609000399 |
News Archive
Asset Recovery Corporation, a leader in environmentally-sound IT asset disposal solutions, announced today that it has been certified by the National Association for Information Destruction (NAID) for computer hard drive sanitization and destruction. Both its plant-based and mobile solutions received certification.
Researchers, including a team from Children's National Health System, have identified head circumference and head tilting reflex as two reliable biomarkers in the identification of autism spectrum disorders (ASD) in children that are between 9 and 12 months of age.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.
"Despite the tremendous progress that has been achieved in the response to HIV/AIDS, it is urgent that efforts be redoubled to end this global epidemic, top United Nations officials stressed Monday, highlighting in particular the need to expand services and scale up resources," the U.N. News Centre reports.
› Verified 6 days ago
Entity Name | Advanced Cardiovascular Specialists Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366416919 PECOS PAC ID: 9032179791 Enrollment ID: O20041016000210 |
News Archive
Asset Recovery Corporation, a leader in environmentally-sound IT asset disposal solutions, announced today that it has been certified by the National Association for Information Destruction (NAID) for computer hard drive sanitization and destruction. Both its plant-based and mobile solutions received certification.
Researchers, including a team from Children's National Health System, have identified head circumference and head tilting reflex as two reliable biomarkers in the identification of autism spectrum disorders (ASD) in children that are between 9 and 12 months of age.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.
"Despite the tremendous progress that has been achieved in the response to HIV/AIDS, it is urgent that efforts be redoubled to end this global epidemic, top United Nations officials stressed Monday, highlighting in particular the need to expand services and scale up resources," the U.N. News Centre reports.
› Verified 6 days ago
Entity Name | Cardiac Cath Lab Of Beaumont, Lp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215233374 PECOS PAC ID: 2466630421 Enrollment ID: O20110623000047 |
News Archive
Asset Recovery Corporation, a leader in environmentally-sound IT asset disposal solutions, announced today that it has been certified by the National Association for Information Destruction (NAID) for computer hard drive sanitization and destruction. Both its plant-based and mobile solutions received certification.
Researchers, including a team from Children's National Health System, have identified head circumference and head tilting reflex as two reliable biomarkers in the identification of autism spectrum disorders (ASD) in children that are between 9 and 12 months of age.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.
"Despite the tremendous progress that has been achieved in the response to HIV/AIDS, it is urgent that efforts be redoubled to end this global epidemic, top United Nations officials stressed Monday, highlighting in particular the need to expand services and scale up resources," the U.N. News Centre reports.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Jorge A Hernandez, MD 755 N 11th St, Suite P2200, Beaumont, TX 77702-1500 Ph: (409) 892-1192 | Jorge A Hernandez, MD 755 N 11th St, Suite P2200, Beaumont, TX 77702-1500 Ph: (409) 892-1192 |
News Archive
Asset Recovery Corporation, a leader in environmentally-sound IT asset disposal solutions, announced today that it has been certified by the National Association for Information Destruction (NAID) for computer hard drive sanitization and destruction. Both its plant-based and mobile solutions received certification.
Researchers, including a team from Children's National Health System, have identified head circumference and head tilting reflex as two reliable biomarkers in the identification of autism spectrum disorders (ASD) in children that are between 9 and 12 months of age.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.
"Despite the tremendous progress that has been achieved in the response to HIV/AIDS, it is urgent that efforts be redoubled to end this global epidemic, top United Nations officials stressed Monday, highlighting in particular the need to expand services and scale up resources," the U.N. News Centre reports.
› Verified 6 days ago
Dr. Michael Ong, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2965 Harrison St, Ste 211, Beaumont, TX 77702 Phone: 409-899-4231 Fax: 409-899-5264 | |
Dr. James Carlton Robinson, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2965 Harrison St, 116, Beaumont, TX 77702 Phone: 409-892-1003 | |
Ahmed A Abdelhakeem, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: Baptist Hospitals Of Southeast Texas, 3282 College Street, Beaumont, TX 77701 Phone: 409-212-7463 | |
Dr. Mustafa Ibrahim Musa, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 755 N 11th St, Suite P-5200, Beaumont, TX 77702 Phone: 409-898-2994 Fax: 409-899-5542 | |
Dr. Aamer Janjua, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6345 Ellington Ln, Beaumont, TX 77706 Phone: 409-504-9972 Fax: 409-861-4949 | |
Syed Imtiaz Anwar, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3570 College St, Suite 200, Beaumont, TX 77701 Phone: 409-833-9797 Fax: 409-654-6803 | |
Robert C. Hood, M.D.,F.R.C.P.C. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3030 North St, Suite 560, Beaumont, TX 77702 Phone: 409-835-9834 Fax: 409-835-7623 |